Xylem Inc <XYL.N>: UBS raises target price to $138 from $135
XYL•Related News
US Stocks Snapshot-Wall St opens higher as investors weigh weaker oil, PPI data
SPY•
Accendra Health Inc <ACH.N>: UBS cuts target price to $1.5 from $4.5
ACH•
UK's Unite Says Actively Engaging With Legal Counsel Over EasyJet Acquisition By Apollo
APO•
Vivakor signs indication of interest for potential equity-swap deal for M2i Global
VIVK•
Odysight.ai signs agreement with Boeing to demonstrate AI-powered predictive maintenance platform
ODYS•